Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype Kevin D. Brown Review 08 December 2012 Pages: 329 - 336
Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis Sebastien AntoniAnnie J. SascoValerie McCormack Review 13 December 2012 Pages: 337 - 347
Trastuzumab administration during pregnancy: a systematic review and meta-analysis Flora ZagouriTheodoros N. SergentanisRupert Bartsch Review 15 December 2012 Pages: 349 - 357
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism Jennifer L. AllensworthScott J. SauerGayathri R. Devi Preclinical Study 07 December 2012 Pages: 359 - 371
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Jessica BockhornKathy YeeHuiping Liu Preclinical study 07 December 2012 Pages: 373 - 382
Vimentin DNA methylation predicts survival in breast cancer Jacob UlirschCheng FanTheresa Swift-Scanlan Preclinical study 13 December 2012 Pages: 383 - 396
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit Josefine BostnerElin KarlssonOlle Stål Preclinical Study Open access 15 December 2012 Pages: 397 - 406
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes Lars C. HankerAchim RodyThomas Karn Preclinical Study 16 December 2012 Pages: 407 - 416
Differential expression of immune-related markers in breast cancer by molecular phenotypes Junjeong ChoiDo Hee KimJa Seung Koo Preclinical Study 16 December 2012 Pages: 417 - 429
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features Purevsuren JambalMelanie M. BadtkeBritta M. Jacobsen Preclinical Study 18 December 2012 Pages: 431 - 448
Effect of HER2 status on distant recurrence in early stage breast cancer Kenneth R. HessFrancisco J. Esteva Clinical trial 06 December 2012 Pages: 449 - 455
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen Denise A. YardleyLowell HartYasir Nagarwala Clinical Trial Open access 08 December 2012 Pages: 457 - 464
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients Holm EggemannAtanas IgnatovSerban-Dan Costa Clinical trial 09 December 2012 Pages: 465 - 470
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer Massimo CristofanilliStephen R. D. JohnstonMaureen E. Trudeau Clinical Trial Open access 13 December 2012 Pages: 471 - 482
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer Cynthia X. MaMatthew J. C. EllisPaula M. Fracasso Clinical trial Open access 15 December 2012 Pages: 483 - 492
Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage Susan K. ConroyBrenna C. McDonaldAndrew J. Saykin Clinical Trial 22 December 2012 Pages: 493 - 502
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer Markus WallwienerAndreas Daniel HartkopfTanja Natascha Fehm Clinical trial 28 December 2012 Pages: 503 - 510
Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk Hong WangZiang YangHongwei Zhang Epidemiology 27 November 2012 Pages: 511 - 522
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer Naoki HayashiNaoki NiikuraNaoto T. Ueno Epidemiology 27 November 2012 Pages: 523 - 531
Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations Darya ProkofyevaNatalia BogdanovaThilo Dörk Epidemiology 06 December 2012 Pages: 533 - 539
Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry Fang Fang ZhangEsther M. JohnMary Beth Terry Epidemiology 06 December 2012 Pages: 541 - 551
Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis Noel PabalanHamdi JarjanaziHilmi Ozcelik Epidemiology 06 December 2012 Pages: 553 - 558
Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population Lilian JaraPatricio Gonzalez-HormazabalGigia Roizen Epidemiology 07 December 2012 Pages: 559 - 569
Impact of breast cancer on anti-mullerian hormone levels in young women H. I. SuS. W. FlattA. Z. Steiner Epidemiology 09 December 2012 Pages: 571 - 577
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age Christopher I. LiElisabeth F. BeaberKathleen E. Malone Epidemiology 09 December 2012 Pages: 579 - 587
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program Joan E. CunninghamChristine A. WaltersCharles L. Bennett Epidemiology 13 December 2012 Pages: 589 - 598
Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case–control study K. BilinskiJ. Boyages Epidemiology 14 December 2012 Pages: 599 - 607
One-day core needle biopsy in a breast clinic: 4 years experience Joris P. BulteLenny PolmanJohannes H. W. De Wilt Epidemiology 14 December 2012 Pages: 609 - 616
Pain in long-term breast cancer survivors: the role of body mass index, physical activity, and sedentary behavior Laura P. ForsytheCatherine M. AlfanoRachel Ballard-Barbash Epidemiology 15 December 2012 Pages: 617 - 630
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer Windy Dean-ColombKenneth R. HessFrancisco J. Esteva Epidemiology 15 December 2012 Pages: 631 - 636
PTP1B expression is an independent positive prognostic factor in human breast cancer S. SoysalE. C. ObermannS. Muenst Epidemiology 16 December 2012 Pages: 637 - 644
Unincluded subjects need to be included for concerning the real association between TNFa−308 G/A polymorphism and cancer susceptibility Guoqiang ZhangZengyan LiuZhenlin Yang Letter to the Editor 27 November 2012 Pages: 645 - 646
Comments on the use of a single or multiple probe-set approach for microarray-based analyses of routine molecular markers in breast cancer Danila CoradiniFederico AmbrogiPatrizia Boracchi Letter To the Editor 19 December 2012 Pages: 647 - 651